Mei‐Yan Wei

1.5k total citations
66 papers, 1.3k citations indexed

About

Mei‐Yan Wei is a scholar working on Pharmacology, Biotechnology and Organic Chemistry. According to data from OpenAlex, Mei‐Yan Wei has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pharmacology, 36 papers in Biotechnology and 21 papers in Organic Chemistry. Recurrent topics in Mei‐Yan Wei's work include Microbial Natural Products and Biosynthesis (44 papers), Marine Sponges and Natural Products (35 papers) and Bioactive Compounds and Antitumor Agents (6 papers). Mei‐Yan Wei is often cited by papers focused on Microbial Natural Products and Biosynthesis (44 papers), Marine Sponges and Natural Products (35 papers) and Bioactive Compounds and Antitumor Agents (6 papers). Mei‐Yan Wei collaborates with scholars based in China, United Kingdom and Switzerland. Mei‐Yan Wei's co-authors include Chang‐Lun Shao, Chang‐Yun Wang, Yu‐Cheng Gu, Yongcheng Lin, Zhigang She, Yang Hai, Dongsheng Deng, Guang‐Ying Chen, Pei‐Yuan Qian and Feifei Guan and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and RSC Advances.

In The Last Decade

Mei‐Yan Wei

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei‐Yan Wei China 23 809 602 318 314 117 66 1.3k
Shengrong Liao China 26 923 1.1× 637 1.1× 506 1.6× 499 1.6× 112 1.0× 77 1.7k
Shengxin Cai China 24 755 0.9× 448 0.7× 300 0.9× 458 1.5× 163 1.4× 45 1.3k
Xiaowei Luo China 21 827 1.0× 583 1.0× 193 0.6× 320 1.0× 82 0.7× 67 1.1k
Min‐Juan Xu China 23 439 0.5× 279 0.5× 291 0.9× 518 1.6× 152 1.3× 55 1.2k
Wen‐Jian Lan China 23 616 0.8× 482 0.8× 263 0.8× 353 1.1× 119 1.0× 76 1.2k
Caiguo Huang China 23 676 0.8× 472 0.8× 297 0.9× 624 2.0× 143 1.2× 51 1.5k
Jioji N. Tabudravu United Kingdom 22 549 0.7× 412 0.7× 268 0.8× 617 2.0× 80 0.7× 55 1.2k
Susan Matthew United States 25 518 0.6× 439 0.7× 282 0.9× 591 1.9× 197 1.7× 41 1.5k
Zhihui Zheng China 21 622 0.8× 294 0.5× 259 0.8× 544 1.7× 133 1.1× 69 1.2k

Countries citing papers authored by Mei‐Yan Wei

Since Specialization
Citations

This map shows the geographic impact of Mei‐Yan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Yan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Yan Wei more than expected).

Fields of papers citing papers by Mei‐Yan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Yan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Yan Wei. The network helps show where Mei‐Yan Wei may publish in the future.

Co-authorship network of co-authors of Mei‐Yan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Yan Wei. A scholar is included among the top collaborators of Mei‐Yan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Yan Wei. Mei‐Yan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yilin, Mei‐Yan Wei, Wenqing Jiang, et al.. (2025). Marine natural products as potential anti-Pseudomonas aeruginosa agents: challenges and advances. European Journal of Medicinal Chemistry. 292. 117670–117670. 1 indexed citations
2.
Wang, Cuifang, Wenhui Wang, Ying Xu, et al.. (2025). Screening, Discovery, and Optimization of the Natural Antitubercular Chlorflavonin from a Marine-Derived Fungal Library. Journal of Natural Products. 88(2). 522–529.
3.
4.
5.
6.
7.
Chen, Jin, Xu Li, Xueqing Zhang, et al.. (2023). Discovery of a natural small-molecule AMP-activated kinase activator that alleviates nonalcoholic steatohepatitis. Marine Life Science & Technology. 5(2). 196–210. 23 indexed citations
8.
Wei, Mei‐Yan, et al.. (2023). A Terphenyllin Derivative CHNQD-00824 from the Marine Compound Library Induced DNA Damage as a Potential Anticancer Agent. Marine Drugs. 21(10). 512–512. 3 indexed citations
9.
Wei, Mei‐Yan, et al.. (2023). Analogues of natural products yaequinolones as potential inflammatory inhibitors: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 250. 115183–115183. 5 indexed citations
10.
Hai, Yang, et al.. (2022). Trends of antimalarial marine natural products: progresses, challenges and opportunities. Natural Product Reports. 39(5). 969–990. 26 indexed citations
11.
Xu, Lili, Xueqing Zhang, Chaojie Wang, et al.. (2022). Discovery, total syntheses and potent anti-inflammatory activity of pyrrolinone-fused benzoazepine alkaloids Asperazepanones A and B from Aspergillus candidus. Communications Chemistry. 5(1). 80–80. 22 indexed citations
12.
Wei, Mei‐Yan, et al.. (2022). Scalable total synthesis of (+)-aniduquinolone A and its acid-catalyzed rearrangement to aflaquinolones. Communications Chemistry. 5(1). 35–35. 13 indexed citations
13.
Wei, Mei‐Yan, et al.. (2022). Highly efficient and scalable total syntheses and stereochemical assignment of potent anti-inflammatory pesimquinolones I and J. Organic Chemistry Frontiers. 10(4). 852–858. 5 indexed citations
14.
15.
Gao, Yang, Jianyu Liu, Ying Xu, et al.. (2022). Design and Characterization of a Natural Arf-GEFs Inhibitor Prodrug CHNQD-01255 with Potent Anti-Hepatocellular Carcinoma Efficacy In Vivo. Journal of Medicinal Chemistry. 65(18). 11970–11984. 13 indexed citations
16.
Hai, Yang, Wei-Ping Ma, Mei‐Yan Wei, et al.. (2022). Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma. European Journal of Medicinal Chemistry. 232. 114166–114166. 3 indexed citations
17.
Chen, Guang‐Ying, et al.. (2021). Semi-Synthesis, Cytotoxic Evaluation, and Structure—Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity. Marine Drugs. 20(1). 26–26. 9 indexed citations
18.
Xu, Weifeng, Min Liu, Yanwei Wu, et al.. (2020). Structure‐Activity Relationships and Potent Cytotoxic Activities of Terphenyllin Derivatives from a Small Compound Library. Chemistry & Biodiversity. 17(7). e2000207–e2000207. 5 indexed citations
19.
Hou, Xuemei, Weifeng Xu, Yang Hai, et al.. (2020). Targeted Isolation of Asperheptatides from a Coral-Derived Fungus Using LC-MS/MS-Based Molecular Networking and Antitubercular Activities of Modified Cinnamate Derivatives. Journal of Natural Products. 84(1). 11–19. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengrong Liao Breakdown of academic impact, for papers by Shengxin Cai Breakdown of academic impact, for papers by Xiaowei Luo Breakdown of academic impact, for papers by Min‐Juan Xu Breakdown of academic impact, for papers by Wen‐Jian Lan Breakdown of academic impact, for papers by Caiguo Huang Breakdown of academic impact, for papers by Jioji N. Tabudravu Breakdown of academic impact, for papers by Susan Matthew Breakdown of academic impact, for papers by Zhihui Zheng
Rankless by CCL
2026